The prices of Neomycin Sulphate are expected to decline globally in September due to several contributing factors. A key reason for this trend is the low demand from the pharmaceutical and healthcare sectors amid ample market supply. Additionally, as the quarter draws to a close, many manufacturers and distributors are focused on clearing out old stock at reduced prices, which further contributes to the downward trajectory of Neomycin Sulphate prices.

The Mid-Autumn Festival from September 15-17, followed by the Golden Week in early October, is likely to impact the Neomycin Sulphate market in China significantly. As manufacturers and sellers prepare for these holidays, they are likely to prioritize clearing out old stock to avoid excess inventory during the festive period when demand may temporarily decline. This proactive approach can lead to increased supply in the market as sellers may offer discounts or lower prices to expedite sales before the holidays. Consequently, this surge in supply, coupled with a potential decrease in demand during the festive season, could drive down Neomycin Sulphate prices. Additionally, with a focus on inventory management, market participants may adopt more competitive pricing strategies, further contributing to a downward pressure on Neomycin Sulphate prices in the lead-up to the holidays.

A similar trend in Neomycin Sulphate prices is expected in the USA due to a confluence of factors. First, the sharp decline in spot rates, along with a notable decrease in demand, is likely to exert downward pressure on Neomycin Sulphate prices. As market demand weakens and becomes more subdued, carriers are faced with excess supply, further driving prices down. Additionally, the easing of drought conditions and the onset of the rainy season in the Panama Canal have improved shipping logistics, facilitating a steady flow of goods and ensuring ample supply in the US market, which may also contribute to price reductions for Neomycin Sulphate. Furthermore, the US government's implementation of higher tariffs on Chinese imports has affected overall demand, leading consumers to scale back purchases, thereby intensifying the downward pressure on Neomycin Sulphate prices.

In Europe, the recent economic developments, including the sharper-than-expected drop in inflation and the European Central Bank's (ECB) interest rate cuts, are expected to drive down Neomycin Sulphate prices in the region. With inflation declining from 2.8% to 2.4% in August, fueled by falling energy costs, overall business expenses are easing. This reduction in costs is likely to be passed on to consumers, leading to lower Neomycin Sulphate prices. Furthermore, the ECB’s second rate cut this year, aimed at reviving sluggish economic growth, reflects the ongoing economic challenges facing Europe. The weaker growth outlook and persistent geopolitical risks are likely to curb demand for pharmaceuticals, which will add further downward pressure on Neomycin Sulphate prices as suppliers adjust to the slower market conditions.

According to ChemAnalyst analysis, Neomycin Sulphate prices are likely to continue declining due to ongoing weak demand from downstream sectors. Global market uncertainties are expected to prompt consumers to cut back on purchasing, maintaining low demand and putting downward pressure on prices. Furthermore, factors such as higher tariffs on Chinese products and the upcoming Golden Week may also impact Neomycin Sulphate prices globally.